Australia/Canberra: Procter & Gamble Australia Pty. Limited, a Macquarie Park, New South Wales establishment, recalls certain batch/lots of Vicks VapoRub Xtra Strong Vaporizing Ointment from the Australian marketplace due to suspected mispackaging and consequential risks of overdose, allergic reactions including rash, blistering, hives, skin peeling, itching and/or swelling. In addition, steam inhalation by children aged 6 to 10 may result in an increased risk of adverse events such as ocular irritation, headaches, dizziness, nausea and cardiac stress in the form of Tachycardia, all serious health and safety hazards requiring immediate medical intervention to minimize pain and suffering as well as prevent life-altering injury or death.
ACCC: https://bit.ly/3PSL6u8
Direct link: https://www.productsafety.gov.au/recalls/procter-gamble-australia-pty-ltd-%E2%80%94-vicks-vaporub-xtra-strong-100g
Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following topical drugs to relieve Cough and Cold symptoms are subject to this recall:
Filed under: ACCC, Children, Drugs, Eye damage hazard, eye injury | Tagged: ACCC, ACCC PRA number: 2022/19649, Australian Competition & Consumer Commission, cardiac arrest hazard, children, drug, Eye damage hazard, Laceration hazard, Procter & Gamble Australia, Recalls Direct RIN: 16587-2022, VapoRub, Vicks, Vicks VapoRub Xtra Strong Vaporizing Ointment | Leave a comment »